1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Malignant Atrophic Papulosis: new trials by email Literature Review of Malignant Atrophic Papulosis trials Research Report on Malignant Atrophic Papulosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement Baricitinib - Kohlmeier-Degos Disease, Malignant Atrophic Papulosis | Phase 2 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 12 | 2026-02-18 | 2026-09-18 |
| JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease Ruxolitinib - Kohlmeier Degos Disease With Neurologic Involvement, Kohlmeier-Degos Disease | Phase 1 / Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1 | 2023-09-28 | 2026-02-03 |
Arterial Occlusive Diseases (2) · Cardiovascular Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Vascular Diseases (2) · Vasculitis (2)
baricitinib (1) · ruxolitinib (1)
National Heart, Lung, and Blood Institute (NHLBI) (2)
United States (2)